3lxser K, Beissert S. Regulatory T ceils: banned (:ells hr deeades [ J ]. J Invest Dermatol, 2012,132 ( 3 Pt 2 ) :864-87 h.
4Billerbeck E, Thimme tl. CD8 + regulatory T cells in persis- tent human viral intctiuns [ J ]. Hum Immunol, 2008, 69 ( 11 ) :771-775.
5Long S A, Buckner J I1. CD4 + Foxp3 + T regulatory cells in human autoimmunity: more than a numbers game[J]. J lm- munol, 2011,187 ( 5 ) :2061-2066.
6Wang H Y, Wang R F. Regulatory T cells and cancer[J]. Curt Opin Immunol, 2007,19(2):217-223.
7Wood K J, Bushel| A, Jones N D. Immunologic unrespons- iveness to al|oantigen in vivo: a role for regulatory T cells [ J 1. lnmmnol Rev, 2011,241 ( I ) : 119-132.
8Tsai S, Clemente-Casares X, Santamaria P. CI)8( + ) Tregs in atttoimmunity: learning "self"-control from experience [ J ]. (:ell Mol Life Sci, 2011,68 (23) :3781-3795.
9Chapul N, Louafi S, Bardier A, et al. hlentification of CD8 + CD25 Foxp3 + suppressive T cells in colorcctal cancer tissue [ J ]. Gut, 2009,58 (4) :520-529.
10l)ai H, Wan N, Zhang S, et al. Cutting edge: programmed death-1 defines CD8+ CD122+ T cells as regulatory versus memory T cells [ J 1. J lmmunol, 2010,185 (2) :803-807.
4Michel F,Attal Bonnefoy G,Mangino G,et al. CD28 as a molecular amplifier extending TCR ligation and signaling capabilities[J]. Immunity,2001,15(6) :935-945.
5Tsukishiro T,Donnenberg A D,Whiteside T L, Rapid Turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the Circulation of patienis with head and neck cancer[J]. Cancer Immunol Immunother, 2003,52(10) :599-607.
3Van Alderwegen IE,Bruijn JA,De Heer E. T cell subsets immunologi-cally-mediated glomerlonephritis[J].Histology and Histopathology,1997.241.
4Youn J,Lynes MA. Metallothionein-induced spression of cytotoxic T Lymphocyte function:an important immunoregulatory control[J].Toxicological Sciences,1999,(02):199-208.
